Cardiovascular Online: AHA 2023 Study Highlights and Expert Analysis

2023-11-17 19:24:01

Among the numerous studies presented at AHA 2023, 3 in the field of arterial hypertension caught the attention of Béatrice Duly-Bouhanick: KARDIA-1, POP-HT and CRHCP. Learn more in this video which summarizes the key information.

What are the benefits of zilebesiran, a new innovative therapeutic class among interfering RNAs, on blood pressure control? In pregnant women suffering from hypertension during pregnancy, what is the impact of blood pressure control on the outcome of echocardiographic parameters in the 6 weeks following delivery? Does intensive blood pressure control below 130/80 reduce dementia?

Find some answers to all these questions through the results of the studies presented to us by our Expert!

Access exclusive Cardio-online content!

Subscribe

Access interviews Watch session videos Discuss clinical cases And more… I subscribe!
1700267897
#AHA #Conference #News

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.